- Last edited on February 19, 2021
Ziprasidone (Zeldox/Geodon)
Primer
Ziprasidone (Trade name: Zeldox in Canada, and Geodon in the United States) is an antipsychotic in the atypical antipsychotic class commonly used in the treatment of schizophrenia.
Pharmacokinetics
See also article: Introduction to Pharmacology
Pharmacokinetics of Ziprasidone
See also article: Cytochrome (CYP) P450 Metabolism
Ziprasidone: Cytochrome P450 Metabolism
| Substrate of (Metabolized by) | |
|---|---|
| Induces | |
| Inhibits |
Pharmacodynamics
Mechanism of Action
Toxicity
Indications
Dosing
Dosing for Ziprasidone
| Starting | |
|---|---|
| Titration | |
| Maximum | |
| Taper |
Formulations
- Ziprasidone comes in
Monitoring
Contraindications
Absolute
Relative
Drug-Drug Interactions
Side Effects
Adverse Events
Clinical Pearls
Special Populations
Geriatric
See main article: Geriatric Pharmacology
Pediatric
See main article: Pediatric Pharmacology
Obstetric and Fetal
See main article: Obstetric and Fetal Pharmacology
Medically Ill
See main article: Psychotropic Dosing in the Medically Ill